GSK plc (GSK)
Coverage summary
Aardvark Labs Capital Research has covered GSK plc (GSK) since April 30, 2026. The company is in the Healthcare sector. This page lists 3 reports: 3 earnings recaps.
The latest is the Q3 2026 Earnings Recap, published October 29, 2026. The current rating is Outperform, the same in every report since coverage began.
Translations: 2 in Chinese.
All GSK reports
2026-10-29
Recap: Q3 2026
Trelegy Recovers, but HIV Timing and the 2027 Interest Bill Limit the Re-rating
2026-07-29
Recap: Q2 2026
A Settlement-Free Beat, and a £1.9bn Programme That Turns the Patent Cliff From Flat to Rising
2026-04-30
Recap: Q1 2026
Two-Fifths of the Beat Was Legal Settlements and the Camlipixant Bar Moved: We Take the Other Side at 10x